Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Bristol Myers Squibb secures expanded US approval for Camzyos | PharmaVoice

Pharma Tech

Bristol Myers Squibb secures expanded US approval for Camzyos

Oct 1, 2026, 9:21 AM

Read Full Article → Bristol Myers Squibb secures expanded US approval for Camzyos

Bristol Myers Squibb secures expanded US approval for Camzyos

Translate article text

Choose a language and wait for the translated text.

The US FDA has expanded the approved indication for BMS' Camzyos to treat symptomatic oHCM in adults and paediatric patients weighing at least 30 kg.